Colony NorthStar (CLNS) Getting Somewhat Positive News Coverage, Accern Reports

Press coverage about Colony NorthStar (NYSE:CLNS) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony NorthStar earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave news articles about the real estate investment trust an impact score of 45.030290772763 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

Colony NorthStar (CLNS) traded down $0.33 during trading hours on Friday, reaching $10.36. 9,374,800 shares of the company traded hands, compared to its average volume of 3,490,000. Colony NorthStar has a 52-week low of $10.35 and a 52-week high of $14.92. The company has a debt-to-equity ratio of 0.95, a current ratio of 4.64 and a quick ratio of 4.64. The firm has a market capitalization of $5,650.00, a price-to-earnings ratio of -259.00 and a beta of 1.46.

Colony NorthStar (NYSE:CLNS) last posted its quarterly earnings results on Thursday, November 9th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.33. Colony NorthStar had a net margin of 9.00% and a negative return on equity of 0.14%. The firm had revenue of $788.90 million during the quarter, compared to analyst estimates of $695.50 million. The company’s revenue for the quarter was up 271.9% compared to the same quarter last year. equities research analysts expect that Colony NorthStar will post 1.34 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 29th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 10.42%. The ex-dividend date is Thursday, December 28th. Colony NorthStar’s dividend payout ratio (DPR) is presently -2,700.00%.

CLNS has been the subject of several recent research reports. Zacks Investment Research lowered shares of Colony NorthStar from a “hold” rating to a “sell” rating in a research report on Friday, September 22nd. ValuEngine raised shares of Colony NorthStar from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. FBR & Co reissued a “buy” rating and issued a $15.00 price target on shares of Colony NorthStar in a research report on Tuesday, October 3rd. B. Riley reissued a “buy” rating on shares of Colony NorthStar in a research report on Wednesday, November 1st. Finally, JMP Securities raised shares of Colony NorthStar from a “market perform” rating to an “outperform” rating and set a $13.00 price target for the company in a research report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. Colony NorthStar presently has an average rating of “Buy” and a consensus target price of $16.05.

In other news, insider Neale Redington sold 12,500 shares of the firm’s stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $11.74, for a total transaction of $146,750.00. Following the completion of the sale, the insider now owns 182,908 shares of the company’s stock, valued at $2,147,339.92. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, major shareholder Colony Northstar, Inc. acquired 119,115 shares of the company’s stock in a transaction dated Tuesday, October 17th. The shares were purchased at an average cost of $9.04 per share, with a total value of $1,076,799.60. The disclosure for this purchase can be found here. Insiders sold 3,493,363 shares of company stock valued at $42,260,703 in the last three months. Company insiders own 7.99% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at

About Colony NorthStar

Colony NorthStar, Inc is a diversified equity real estate investment trust (REIT). The Company combines a portfolio of real assets across the world, which are managed with a global real estate investment manager. The Company has property holdings in the healthcare, industrial and hospitality sectors, opportunistic equity and debt investments, and an embedded institutional and retail investment management business.

Insider Buying and Selling by Quarter for Colony NorthStar (NYSE:CLNS)

Receive News & Ratings for Colony NorthStar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony NorthStar and related companies with's FREE daily email newsletter.

Leave a Reply